Trial Profile
Phase I trial of APD 209 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2013
Price :
$35
*
At a glance
- Drugs APD 209 (Primary)
- Indications Infectious keratoconjunctivitis; Keratoconjunctivitis
- Focus Adverse reactions
- Sponsors Adenovir Pharma
- 31 Oct 2013 New trial record